FECAL MICROBIOTA CHANGES IN CHILDREN WITH CYSTIC FIBROSIS WITH 1 MONTH OF CFTR MODULATOR THERAPY ELEXACAFTOR/ TEZACAFTOR/IVACAFTOR: PRELIMINARY FINDINGS FROM THE PROMISE PEDIATRICS STUDY

被引：0
|
作者：
Duong, Jennifer T.
Pope, Christopher E.
Hayden, Hillary S.
Miller, Carson
Raftery, Daniel
Salipante, Stephen J.
Pittman, Jessica
Ratjen, Felix
Rosenfeld, Margaret
Hoffman, Lucas R.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1885
引用
收藏
页码：S929 / S930
页数：2
相关论文
共 15 条
  • [1] CHANGES IN FECAL FAT AND MICROBIOTA WITH 1 MONTH OF ELEXACATOR/TEZACAFTOR/IVACAFTOR: INITIAL FINDINGS FROM THE PROMISE STUDY
    Hoffman, L.
    Pope, C.
    Hayden, H.
    Rowe, S.
    Salipante, S.
    Nichols, D. P.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S124 - S124
  • [2] Impact of elexacaftor/tezacaftor/ivacaftor CFTR modulator therapy on rates of endoscopic sinus surgery in cystic fibrosis
    Pingree, Graham
    Bentan, Mihai
    Fitzpatrick, Thomas
    Schuman, Theodore
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (11) : 1692 - 1699
  • [3] Raised Intracranial Pressure in Three Children with Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor Modulator Therapy
    Southern, Kevin W.
    Barben, Jurg
    Goldring, Stephen
    Kneen, Rachel
    Southward, Suzanne
    Rajeev, Yashasvi
    Davies, Jane C.
    Bush, Andrew
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (01) : 103 - 105
  • [4] PREFUL MRI for Monitoring Perfusion and Ventilation Changes after Elexacaftor-Tezacaftor-Ivacaftor Therapy for Cystic Fibrosis: A Feasibility Study
    Dohna, Martha
    Voskrebenzev, Andreas
    Klimes, Filip
    Kaireit, Till F.
    Glandorf, Julian
    Pallenberg, Sophia T.
    Ringshausen, Felix C.
    Hansen, Gesine
    Renz, Diane Miriam
    Wacker, Frank
    Dittrich, Anna-Maria
    Vogel-Claussen, Jens
    RADIOLOGY-CARDIOTHORACIC IMAGING, 2024, 6 (02):
  • [5] Effect of CFTR modulator therapy with elexacaftor/tezacaftor/ivacaftor on pulmonary ventilation derived by 3D phase-resolved functional lung MRI in cystic fibrosis patients
    Filip Klimeš
    Andreas Voskrebenzev
    Marcel Gutberlet
    Milan Speth
    Robert Grimm
    Martha Dohna
    Gesine Hansen
    Frank Wacker
    Diane Miriam Renz
    Anna-Maria Dittrich
    Jens Vogel-Claussen
    European Radiology, 2024, 34 : 80 - 89
  • [6] Effect of CFTR modulator therapy with elexacaftor/tezacaftor/ivacaftor on pulmonary ventilation derived by 3D phase-resolved functional lung MRI in cystic fibrosis patients
    Klimes, Filip
    Voskrebenzev, Andreas
    Gutberlet, Marcel
    Speth, Milan
    Grimm, Robert
    Dohna, Martha
    Hansen, Gesine
    Wacker, Frank
    Renz, Diane Miriam
    Dittrich, Anna-Maria
    Vogel-Claussen, Jens
    EUROPEAN RADIOLOGY, 2024, 34 (01) : 80 - 89
  • [7] Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis
    Stephenson, Kimberly G.
    Lingle, Abby J.
    Baumberger, Kelly A.
    Dellon, Elisabeth P.
    Esther Jr, Charles R.
    Meier, Ellen M.
    Oermann, Christopher M.
    Shenoy, Vivek K.
    Smith, Natalie R.
    Wimmer, Nicole S.
    Duehlmeyer, Stephanie R.
    Kam, Charissa W.
    Mckinzie, Cameron J.
    Poisson, Margaret O.
    Elson, E. Claire
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (06) : 996 - 1001
  • [8] The Influence of the new CFTR Modulator Triple Therapy (Elexacaftor/Tezacaftor/Ivacaftor) after three Months of Treatment on Lung Function, physical Exertion and health-related Quality of Life in Patients with Cystic Fibrosis
    Wollsching-Strobel, M.
    Dieninghoff, D.
    Emrich, F. L.
    Kroppen, D.
    Majorski, D.
    Mathes, T.
    Magnet, S. F.
    Schwarz, S.
    Windisch, W.
    PNEUMOLOGIE, 2022, 76 : S84 - S85
  • [9] Outcomes of triple therapy (elexacaftor/tezacaftor/ivacaftor) in Cystic fibrosis-related diabetes: a real-life case study from a Brazilian reference center
    Zorron, M.
    Guerra-Junior, G.
    Alexandre Pascoa, M.
    Castilho, T.
    Coimbra Teixeira, L.
    Azarite Salomao, M. J.
    De Souza Paiva Borgli, D.
    Cristina Ropoli Bernardino, B.
    Neuenschwander Mendonca, M.
    Faganello Colombo, F.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 118 - 118
  • [10] Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis-a real world study
    Appelt, Dorothea
    Steinkamp, Gratiana
    Sieber, Sarah
    Ellemunter, Helmut
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12